XVIVO PERFUSION AB XVIVO PERFUS (0RKL.L) Financials

0RKL.L Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 ? ?
2023-09-30 2.2 billion 309.0 million
2023-06-30 1.8 billion 285.1 million
2023-03-31 1.7 billion 293.0 million

0RKL.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 18.3 million ?
2023-06-30 8.8 million ?
2023-03-31 -22.7 million ?

0RKL.L Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 68.5 million
2023-09-30 2.3 million
2023-06-30 6.9 million
2023-03-31 14.2 million

0RKL.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 594.3 million - -
2023-06-30 171.4 million - -
2023-03-31 198.0 million - -

0RKL.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 ?
2023-09-30 30.1 million
2023-06-30 29.9 million
2023-03-31 29.8 million

0RKL.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - - -
2023-09-30 6.5 million 27.1 million 11.8 million 58.9 million
2023-06-30 6.9 million 31.6 million 27.3 million 41.2 million
2023-03-31 10.3 million 26.2 million 19.0 million 48.4 million

0RKL.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 146.6 million 39.0 million
2023-06-30 154.6 million 39.1 million
2023-03-31 140.6 million 35.8 million

0RKL.L

Price: SEK403

52 week price:
205.50
403.00

Earnings Per Share: 0.24 SEK

P/E Ratio: 1168.70

Exchange: LSE

Sector: Healthcare

Industry: Health Care Equipment & Services

Market Capitalization: 102.7 million

Links: